Component portfolio and prices

On this page:

 

Component portfolio

Portfolio of blood components and guidance for their clinical use (PDF 1MB)

This provides details of therapeutic blood components including constituents, and information on:

      • specifications
      • identification barcodes
      • quality standards and monitoring
      • storage and handling
      • clinical indications and contraindications
      • specialist requirements
      • dosage, administration, recognition of adverse effects
      • material safety data sheet

 

Apheresis platelets in PAS and plasma 

We started issuing apheresis platelets in platelet additive solution (PAS) and plasma on 12 January 2026, alongside the current apheresis platelets in plasma. You may receive either component after 12 January. Use these identification bar codes (PDF 29KB) to update your LIMS.

Please refer to our FAQs (PDF 484KB) for more information.

New neonatal apheresis platelets in PAS and plasma

The go-live date for this new component is 21 July 2026.  Please advise the relevant clinical areas in your hospital about it.

Refer to the Red Book change notification (PDF 152KB) about the component on the JPAC website for detailed information. 

The component is suspended in a medium comprising 30 to 50% plasma and 50 to 70% additive solution and anticoagulant.

Please ensure you have the identification bar codes in your LIMS system in readiness, using these bar codes, version 2 (PDF 163KB). Version 2 (22 May 2026) has the correct bar code for the component for pack 8 with the Pulse code 0P18.

Both the new and current neonatal apheresis components will be issued to hospitals from 21 July.

Current neonatal apheresis platelets in PAS and plasma

The current neonatal apheresis platelet component has PAS added at manufacture. The PAS/plasma ratio of 20% additive solution, was shared at time of release, approximately 5 years ago.

If you have any questions email michelle.ray@nhsbt.nhs.uk. Michelle is the Projects and Operational Support Lead in the Technical and Scientific Development team. 

 

Component and transport prices



Non stock and special components, including components for urgent requests

It is important you allow for processing and transport time when ordering these components. Please refer to Appendix 7 in the portfolio of blood components (download the PDF file of the portfolio using the link at the top of this page).